At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
COSM COSMOS HEALTH INC
Trading 09-17 13:06:45 EDT
0.3039
+0.0301
+10.99%
High0.3041Low0.2719Vol2.09M
Open0.2734D1 Closing0.2738Amplitude11.76%
Mkt Cap30.69MTradable Cap23.94MTotal Shares101.00M
T/O612.87KT/O Rate2.66%Tradable Shares78.78M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Cosmos Health secures five-year contract manufacturing agreement
TIPRANKS  ·  09-15 22:40
Cosmos Health secures five-year contract manufacturing agreement
Cosmos Health: Prime Ledger to Structure Tokenized Financing Backed by Ip in Ccx0722, an Ingestible Device in Development for Weight Management
THOMSON REUTERS  ·  09-15 04:02
Cosmos Health: Prime Ledger to Structure Tokenized Financing Backed by Ip in Ccx0722, an Ingestible Device in Development for Weight Management
Sector Update: Healthcare Stocks Ease in Afternoon Trading
MT Newswires Live  ·  09-12
Sector Update: Healthcare Stocks Ease in Afternoon Trading
Cosmos Health secures five-year contract manufacturing agreement
TIPRANKS  ·  09-11
Cosmos Health secures five-year contract manufacturing agreement
Cosmos Health: Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Agreement with Viofar
THOMSON REUTERS  ·  09-11
Cosmos Health: Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Agreement with Viofar
Cosmos Health Signs Five-Year Viofar Manufacturing Deal for 2.5 Million Rosartia Units
Reuters  ·  09-11
Cosmos Health Signs Five-Year Viofar Manufacturing Deal for 2.5 Million Rosartia Units
Cosmos Health launches C-ScrubVet in the UK
TIPRANKS  ·  09-09
Cosmos Health launches C-ScrubVet in the UK
Cosmos Health Q2 2026 Adjusted Ebitda Loss Narrows to $1.13 Million; Revenue Rises 28.8% to $18.99 Million Vs. Year Earlier
Reuters  ·  09-03
Cosmos Health Q2 2026 Adjusted Ebitda Loss Narrows to $1.13 Million; Revenue Rises 28.8% to $18.99 Million Vs. Year Earlier
Zacks Small-Cap Research Initiates Cosmos Health Coverage with $4.5 Price Target
Reuters  ·  09-03
Zacks Small-Cap Research Initiates Cosmos Health Coverage with $4.5 Price Target
Cosmos Health: a Company Transformed — 2026 Year-to-Date
THOMSON REUTERS  ·  09-03
Cosmos Health: a Company Transformed — 2026 Year-to-Date
Cosmos Health - 2029 Guidance Reaffirmed: $200.60m Revenue, $71.20m Gross Profit, $31M Net Income, $44.20m Adj Ebitda
THOMSON REUTERS  ·  09-03
Cosmos Health - 2029 Guidance Reaffirmed: $200.60m Revenue, $71.20m Gross Profit, $31M Net Income, $44.20m Adj Ebitda
Press Release: Cosmos Health: a Company Transformed
Dow Jones  ·  09-03
Press Release: Cosmos Health: a Company Transformed
Cosmos Health Retires $8 Million Senior Secured Convertible Note Ahead of Maturity
Reuters  ·  08-28
Cosmos Health Retires $8 Million Senior Secured Convertible Note Ahead of Maturity
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M Atw Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution from Conversions
THOMSON REUTERS  ·  08-28
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M Atw Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution from Conversions
Cosmos Health - Has no Effective Shelf Registration, Atm Program, or Floorless Variable-Rate Instruments
THOMSON REUTERS  ·  08-28
Cosmos Health - Has no Effective Shelf Registration, Atm Program, or Floorless Variable-Rate Instruments
Cosmos Health Inc: Operating Cash Requirements Reduced by More than 30%
THOMSON REUTERS  ·  08-28
Cosmos Health Inc: Operating Cash Requirements Reduced by More than 30%
Cosmos Health Forecasts over $6 Million in Annual U.S. Revenue from Oliv18 Within 12-18 Months
Reuters  ·  08-25
Cosmos Health Forecasts over $6 Million in Annual U.S. Revenue from Oliv18 Within 12-18 Months
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal with Innova Healthcare
Reuters  ·  08-20
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal with Innova Healthcare
Cosmos Health - Exclusive Rights in Saudi Arabia for Initial Five Years, Renewable for Five More
THOMSON REUTERS  ·  08-20
Cosmos Health - Exclusive Rights in Saudi Arabia for Initial Five Years, Renewable for Five More
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement with Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, with More than 5 Million Units Expected over Initial 5-Year Term
THOMSON REUTERS  ·  08-20
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement with Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, with More than 5 Million Units Expected over Initial 5-Year Term

Introduction

Company Name.
COSMOS HEALTH INC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Issue price:
--